期刊文献+

重组生长激素对兔冠状动脉粥样硬化的影响 被引量:3

Effects of recombinant growth hormone on atherosclerosis of rabbits
下载PDF
导出
摘要 目的研究重组生长激素(recombinant growth hormone,rGH)对高胆固醇饮食的新西兰兔血脂及冠状动脉粥样硬化的影响。方法健康新西兰白兔,均为雄性,兔龄4个月,体重(2.2±0.3)kg,随机分为rGH组、对照组(NC)、高胆固醇组(HC),观察高胆固醇饮食的条件下,rGH对血脂和冠状动脉粥样硬化的影响。结果rGH组血清总胆固醇(total cholesterol,TC)、低密度脂蛋白胆固醇(low density lipoprotein-cholesterol,LDL-C)、氧化修饰低密度脂蛋白(oxidized low density lipoprotein,oxLDL)、低于对照组(P<0.01),但对甘油三酯(triglycerides,TG)和高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)无明显影响。rGH组狭窄冠状动脉的百分比和管腔狭窄程度均低于对照组。结论rGH能够有效地降低高胆固醇饮食条件下TC、LDL-C、oxLDL及抑制冠状动脉粥样硬化的发生。 Objectlve To study the effect of recombinant growth hormone (rGH) on serum lipid levels and coronary atherosclerosis of rabbits by high-cholesterol diet. Methods Four-month-old male rabbits with high-cholesterol diet were randomly divided into four groups; control group, HCgroup, HC+ 0. 2rGHgroup and HC+0. 4rGH group. Serum lipids were measured after 3 months,coronary atherosclerosls were measured after 3 months. Results As compared with control group,rGH group had lower levels of serum TC,LDL-C and oxLDL,but no change for serum TG and HDL-C. The percentage and various degrees of stenosis of coronary in rGH group were lower than those of HC group. Conclusion rGH can improve serum lipids and inhibit coronary atherosclerosis of ribitts with high-cholesterol diet.
出处 《重庆医学》 CAS CSCD 2008年第6期572-573,577,F0002,共4页 Chongqing medicine
关键词 重组生长激素 动脉粥样硬化 血脂 recombinant growth hormone, serum lipids coronary atherosclerosis
  • 相关文献

参考文献8

  • 1Boguszewski CL, Meister LH, Zaninelli DC, et al. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults[J]. Endocrinol, 2005,152 ( 1 ) : 67. 被引量:1
  • 2Elgzyri T,Castenfors J,Hagg E,et al. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency[J]. Clin endocrinol (Oxf), 2004, 61 (1) : 113. 被引量:1
  • 3张彤,徐成斌,张新超,金晓峰.普伐他汀和西立伐他汀对高胆固醇喂养兔的血管内皮功能的影响[J].中国病理生理杂志,2000,16(12):1324-1326. 被引量:3
  • 4Wallis M. In: De I.a Cruzed. Regulation of growth hormone and somatic growth[M]. Elsever Science Publisher, 1992,2:852. 被引量:1
  • 5Weltman A,Despres J P,Clasey J L,et al. hnpact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older aduhs[J]. Metabolism, 2003,52(1) :73. 被引量:1
  • 6Fideleff H L, Boquete H,Giaccio A, et al. Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults[J]. Medicina(B Aires),2006,66 (4) :296. 被引量:1
  • 7van der Klaauw A A, Romijn J A, Biermasz N R,et al. Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency[J]. Endocrinology,2006,155(5) :701. 被引量:1
  • 8傅春江,王旭开,杨成明,王红勇,方玉强,石伟彬.重组生长激素对兔血脂及肝脏LDL受体mRNA的影响[J].第三军医大学学报,2005,27(8):753-755. 被引量:9

二级参考文献10

  • 1Liao J K,J Bio Chem,1995年,270卷,319页 被引量:1
  • 2De Boer H, Blok G J, Voerman H J, et al. Serum lipid levels in growth hormone-deficient men[J]. Metabolism, 1994, 43(2): 199-203. 被引量:1
  • 3Li Voon Chong J S, Benbow S, Foy P, et al. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects[J]. Clin endocrinol(Oxf), 2000, 53(5): 551-559. 被引量:1
  • 4Hassan H M, Kohno H, Kuromaru R, et al. Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment[ J].Acta Paediatr, 1996, 85(8): 899 - 901. 被引量:1
  • 5Weltman A, Despres J P, Clasey J L, et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults[J]. Metabolism, 2003, 52(1): 73-80. 被引量:1
  • 6Van Pareren Y K, De Muinck Keizer Schrana S M, Stijnen T, et al. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome[J]. J Clin Endocrinol Metab, 2002, 87(12): 5442-5448. 被引量:1
  • 7Florakis D, Hung V, Kaltsas G, et al. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study[J]. Clin Endocrinol (Oxf),2000, 53(4): 453-459. 被引量:1
  • 8l' Allemand D, Eiholzer U, Schlumpf M, et al. Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome[J]. Eur J Pediatr, 2000, 159( 11 ): 835 - 842. 被引量:1
  • 9郑晓伟,曾定尹,王晓静,陈燕,邢福琴,石玉秀,李建华.血脂康对高脂饮食家兔血管内皮细胞功能的保护作用[J].中华内科杂志,1998,37(6):367-370. 被引量:31
  • 10张彤,徐成斌,张新超,金晓峰.普伐他汀和西立伐他汀对高胆固醇喂养兔的血管内皮功能的影响[J].中国病理生理杂志,2000,16(12):1324-1326. 被引量:3

共引文献9

同被引文献25

  • 1Kemp SF, Frindik JP. Emerging options in growth hormone therapy: an update[J]. Drug Des Devel Ther, 2011, 5(1): 411- 419. 被引量:1
  • 2Frindik JP, Kemp SF. Managing idiopathic short stature: role of somatropin (rDNA origin) for injection[J]. Biologics, 2010, 4(1): 147-155. 被引量:1
  • 3Harvey S. Extrapituitary growth hormone[J]. Endocrine, 2010, 38(3): 335-359. 被引量:1
  • 4Gotherstrom G, Bengtsson BA, Sunnerhagen KS, et al. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients[J]. Clin Endocrinol (Oxf), 2005, 62(1): 105-113. 被引量:1
  • 5Burgert TS, Vuguin PM, Dimartino-Nardi J, et al. Assessing insulin resistance: application of a fasting glucose to insulin ratio in growth hormone-treated children[J]. Horm Res, 2002, 57(1-2): 37-42. 被引量:1
  • 6Quigley CA, Gill AM, Crowe B J, et al. Safety of growth hormone treatment in pediatric patients with idiopathic short stature[J]. J Clin Endocrinol Metab, 2005, 90(9): 5188-5196. 被引量:1
  • 7Cutfield WS, Wilton P, Bennmarker H, et al. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment[J]. Lancet, 2000, 355(9204): 610-613. 被引量:1
  • 8Lebrtm P, Van Obberghen E. SOCS proteins causing trouble in insulin action[J]. Acta Physiol (Oxf), 2008, 192(1): 29-36. 被引量:1
  • 9Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia[J]. Eur J Endocrinol, 2007, 157(6): 695-700. 被引量:1
  • 10Louveau I, Gondret F. Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system[J]. Domest Anim Endoerinol, 2004, 27(3): 241-255. 被引量:1

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部